Guinea-Bissau

Guinea-Bissau

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
10.82 (9.02 - 12.39) 2019 Modelled IHME
11.83 (9.67 - 13.59) 2018 Modelled IHME
12.26 (9.99 - 14.31) 2017 Modelled IHME
12.09 (9.94 - 14.12) 2016 Modelled IHME
11.93 (9.81 - 14.04) 2015 Modelled IHME
12.1 (9.97 - 14.12) 2014 Modelled IHME
12.51 (10.37 - 14.51) 2013 Modelled IHME
13.06 (10.88 - 15.13) 2012 Modelled IHME
13.62 (11.26 - 15.81) 2011 Modelled IHME
14.07 (11.53 - 16.51) 2010 Modelled IHME
14.44 (11.81 - 16.80) 2009 Modelled IHME
14.82 (12.10 - 17.14) 2008 Modelled IHME
15.17 (12.33 - 17.60) 2007 Modelled IHME
15.44 (12.55 - 18.08) 2006 Modelled IHME
15.58 (12.55 - 18.38) 2005 Modelled IHME
15.64 (12.65 - 18.30) 2004 Modelled IHME
15.68 (12.70 - 18.28) 2003 Modelled IHME
15.71 (12.72 - 18.38) 2002 Modelled IHME
15.74 (12.74 - 18.50) 2001 Modelled IHME
15.79 (12.79 - 18.58) 2000 Modelled IHME
15.92 (12.91 - 18.67) 1999 Modelled IHME
16.13 (13.04 - 18.85) 1998 Modelled IHME
16.36 (13.17 - 19.11) 1997 Modelled IHME
16.56 (13.28 - 19.42) 1996 Modelled IHME
16.66 (13.25 - 19.67) 1995 Modelled IHME
16.69 (13.40 - 19.72) 1994 Modelled IHME
16.71 (13.40 - 19.81) 1993 Modelled IHME
16.73 (13.45 - 19.90) 1992 Modelled IHME
16.74 (13.47 - 19.96) 1991 Modelled IHME
16.73 (13.43 - 20.09) 1990 Modelled IHME
5.11 (0.41 - 38.31) 2015 Modelled WHO
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
3.77 (2.78 - 4.70) 2019 Modelled IHME
3.98 (2.92 - 5.02) 2018 Modelled IHME
4.02 (2.85 - 5.22) 2017 Modelled IHME
3.75 (2.71 - 4.80) 2016 Modelled IHME
3.46 (2.55 - 4.47) 2015 Modelled IHME
3.43 (2.50 - 4.39) 2014 Modelled IHME
3.4 (2.50 - 4.30) 2013 Modelled IHME
3.39 (2.47 - 4.27) 2012 Modelled IHME
3.38 (2.46 - 4.25) 2011 Modelled IHME
3.37 (2.44 - 4.27) 2010 Modelled IHME
4.32 (3.14 - 5.42) 2009 Modelled IHME
6.6 (4.78 - 8.22) 2008 Modelled IHME
9.32 (6.77 - 11.57) 2007 Modelled IHME
11.62 (8.39 - 14.58) 2006 Modelled IHME
12.62 (8.98 - 16.21) 2005 Modelled IHME
12.68 (9.02 - 16.21) 2004 Modelled IHME
12.71 (9.02 - 16.27) 2003 Modelled IHME
12.73 (9.02 - 16.43) 2002 Modelled IHME
12.75 (9.04 - 16.61) 2001 Modelled IHME
12.79 (8.96 - 16.84) 2000 Modelled IHME
12.89 (9.01 - 16.82) 1999 Modelled IHME
13.06 (9.18 - 16.84) 1998 Modelled IHME
13.27 (9.38 - 16.91) 1997 Modelled IHME
13.44 (9.52 - 17.07) 1996 Modelled IHME
13.54 (9.55 - 17.34) 1995 Modelled IHME
13.59 (9.66 - 17.28) 1994 Modelled IHME
13.63 (9.69 - 17.23) 1993 Modelled IHME
13.67 (9.73 - 17.44) 1992 Modelled IHME
13.7 (9.73 - 17.45) 1991 Modelled IHME
13.72 (9.67 - 17.69) 1990 Modelled IHME
2.12 (0.18 - 20.45) 2015 Modelled WHO
Showing out of
Show more

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
51 (42 - 60) 2019 Modelled IHME
52 (44 - 61) 2018 Modelled IHME
52 (44 - 61) 2017 Modelled IHME
52 (44 - 61) 2016 Modelled IHME
52 (44 - 61) 2015 Modelled IHME
52 (44 - 61) 2014 Modelled IHME
52 (43 - 61) 2013 Modelled IHME
52 (43 - 61) 2012 Modelled IHME
52 (43 - 61) 2011 Modelled IHME
52 (43 - 61) 2010 Modelled IHME
52 (43 - 61) 2009 Modelled IHME
52 (44 - 61) 2008 Modelled IHME
53 (44 - 61) 2007 Modelled IHME
53 (45 - 61) 2006 Modelled IHME
53 (45 - 62) 2005 Modelled IHME
53 (45 - 62) 2004 Modelled IHME
53 (44 - 62) 2003 Modelled IHME
53 (44 - 62) 2002 Modelled IHME
53 (44 - 62) 2001 Modelled IHME
53 (45 - 62) 2000 Modelled IHME
53 (45 - 62) 1999 Modelled IHME
53 (45 - 62) 1998 Modelled IHME
53 (45 - 62) 1997 Modelled IHME
53 (45 - 62) 1996 Modelled IHME
53 (45 - 62) 1995 Modelled IHME
53 (45 - 62) 1994 Modelled IHME
53 (45 - 62) 1993 Modelled IHME
53 (45 - 62) 1992 Modelled IHME
53 (44 - 63) 1991 Modelled IHME
53 (44 - 62) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
88 2018 Survey/reported WHO/UNICEF
88 2017 Survey/reported WHO/UNICEF
88 2016 Survey/reported WHO/UNICEF
88 2015 Survey/reported WHO/UNICEF
88 2014 Survey/reported WHO/UNICEF
87 2013 Survey/reported WHO/UNICEF
87 2012 Survey/reported WHO/UNICEF
89 2011 Survey/reported WHO/UNICEF
82 2010 Survey/reported WHO/UNICEF
80 2009 Survey/reported WHO/UNICEF
Showing out of
Show more
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
No
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
2.02 (1.62 - 2.53) 2019 Modelled IHME
2.02 (1.61 - 2.57) 2018 Modelled IHME
2.03 (1.61 - 2.58) 2017 Modelled IHME
2.05 (1.65 - 2.56) 2016 Modelled IHME
2.06 (1.67 - 2.56) 2015 Modelled IHME
2.05 (1.66 - 2.54) 2014 Modelled IHME
2.03 (1.64 - 2.51) 2013 Modelled IHME
2 (1.60 - 2.48) 2012 Modelled IHME
1.97 (1.58 - 2.46) 2011 Modelled IHME
1.96 (1.56 - 2.44) 2010 Modelled IHME
1.97 (1.57 - 2.45) 2009 Modelled IHME
1.99 (1.58 - 2.48) 2008 Modelled IHME
2.01 (1.60 - 2.52) 2007 Modelled IHME
2.04 (1.63 - 2.57) 2006 Modelled IHME
2.06 (1.65 - 2.59) 2005 Modelled IHME
2.08 (1.66 - 2.60) 2004 Modelled IHME
2.1 (1.68 - 2.61) 2003 Modelled IHME
2.11 (1.70 - 2.63) 2002 Modelled IHME
2.13 (1.71 - 2.65) 2001 Modelled IHME
2.15 (1.74 - 2.67) 2000 Modelled IHME
2.2 (1.78 - 2.73) 1999 Modelled IHME
2.27 (1.83 - 2.82) 1998 Modelled IHME
2.34 (1.88 - 2.92) 1997 Modelled IHME
2.42 (1.93 - 3.03) 1996 Modelled IHME
2.46 (1.97 - 3.09) 1995 Modelled IHME
2.5 (2 - 3.13) 1994 Modelled IHME
2.52 (2.04 - 3.17) 1993 Modelled IHME
2.55 (2.05 - 3.20) 1992 Modelled IHME
2.56 (2.07 - 3.23) 1991 Modelled IHME
2.57 (2.07 - 3.24) 1990 Modelled IHME
Showing out of
Show more

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
17 (12 - 23) 2019 Modelled IHME
17 (11 - 23) 2018 Modelled IHME
16 (11 - 23) 2017 Modelled IHME
16 (11 - 23) 2016 Modelled IHME
17 (11 - 22) 2015 Modelled IHME
17 (11 - 23) 2014 Modelled IHME
17 (11 - 22) 2013 Modelled IHME
17 (12 - 23) 2012 Modelled IHME
17 (11 - 22) 2011 Modelled IHME
17 (11 - 23) 2010 Modelled IHME
17 (11 - 22) 2009 Modelled IHME
17 (11 - 22) 2008 Modelled IHME
16 (11 - 22) 2007 Modelled IHME
16 (11 - 22) 2006 Modelled IHME
16 (11 - 22) 2005 Modelled IHME
16 (11 - 22) 2004 Modelled IHME
16 (11 - 22) 2003 Modelled IHME
16 (11 - 22) 2002 Modelled IHME
16 (11 - 22) 2001 Modelled IHME
16 (11 - 22) 2000 Modelled IHME
16 (11 - 22) 1999 Modelled IHME
16 (11 - 22) 1998 Modelled IHME
16 (11 - 22) 1997 Modelled IHME
16 (11 - 22) 1996 Modelled IHME
16 (11 - 22) 1995 Modelled IHME
16 (11 - 22) 1994 Modelled IHME
16 (11 - 22) 1993 Modelled IHME
16 (11 - 22) 1992 Modelled IHME
16 (11 - 22) 1991 Modelled IHME
16 (11 - 22) 1990 Modelled IHME
Showing out of
Show more
Technical notes
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
No
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines

Overview

HBV elimination goal
HCV elimination goal

Prevalence (national)

Modelled

HBV (HBsAg+)
10.82 (%)
2019
(9.02 - 12.39(%))
IHME
HCV (RNA/cAg+)
2.02 (%)
2019
(1.62 - 2.53(%))
IHME

Survey/surveillance

No data available
No data available

Hepatitis related deaths (national)

Modelled

HBV
241
2019
(172 - 331)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
38
2019
(25 - 56)
IHME

Survey/surveillance

No data available
HCV chart

Prevalence < 5

HBV
3.77 (%)
2019, latest modelled
(2.78 - 4.70(%))
IHME

Prevalence PWID

No data available

Birth dose vaccination coverage (national)

Survey/surveillance

No data available

No. of syringes/PWID/year

Survey/surveillance

No data available
Eligible for HBV generic medicines
Eligible for HCV generic medicines